Background {#Sec1}
==========

Diabetic nephropathy is a common complication in diabetes mellitus and often results in the need for dialysis or kidney transplantation. The excessive ROS production in diabetes is considered as a direct consequence of hyperglycemia \[[@CR1]\]. The pathogenesis of diabetic nephropathy also involves strong association between both increased oxidative stress and kidney tissue hypoxia. The enhanced oxidative stress has been suggested to impair tubular electrolyte efficiency and produce mitochondrial derangements in kidney resulting in increased oxygen consumption (QO~2~), and reduced oxygen tension (PO~2~) \[[@CR2], [@CR3]\]. The reduced kidney PO~2~ is manifested as hypoxia which can induce immune cell infiltration, proteinuria and tubulointerstitial fibrosis, all considered as pathological hallmarks of chronic kidney diseases \[[@CR4], [@CR5]\]. Importantly, the renal hypoxia is now recognised as an independent risk factor for development of nephropathy \[[@CR6]\].

HIFs modulate key metabolic pathways to optimize glucose and O~2~ utilization for generation of sufficient amounts of ATP. It is comprised of two different subunits: an α-subunit that is rapidly deteriorated by prolyl hydroxylases in the presence of oxygen and a constitutively expressed β-subunit. During oxygen deprivation in hypoxic sate HIF-1α accumulation occurs which combines with β subunit to form transcriptionally active heterodimer that subsequently remodels the renal hemodynamics by producing blood cells and by inducing formation of new vessels via targeting erythropoietin and vascular endothelium growth factor (VEGF) \[[@CR7], [@CR8]\]. In addition a study has demonstrated that pharmacological activation of HIFs by cobalt treatment prevented the diabetes-induced alterations in oxygen metabolism, mitochondrial leak respiration, kidney function and reduced proteinuria and tubulointerstitial damage \[[@CR9]\].

The current therapeutic approaches for treatment of diabetic nephropathy includes use of angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers and antihypertensive drugs. However these agents may not be completely effective in halting the progression of diabetic nephropathy. Carbohydrate energy restriction has been reported to improve physical endurance and reduce brain oxidative damage against exhaustive exercise test in rats \[[@CR10]\]. Another study has demonstrated that beneficial effects of the low sucrose diet intake on ischemia reperfusion induced renal injury in mice. One week of low carbohydrate dietary preconditioning in mice reduced postoperative weight loss and improved renal dysfunction in mice subjected to bilateral renal ischemic injury \[[@CR11]\]. Kume et al., 2010 \[[@CR12]\] reported that long term general calorie restriction promotes cellular adaptive mechanisms in response to aging associated renal hypoxia in mice. Furthermore dietary calorie restriction exposure (9 weeks) in diabetic rats was found to exert protective effects by reducing the oxidative damage and inflammatory response in rat kidney \[[@CR13]\]. Importantly carbohydrate restriction in humans is now recognised as an efficacious and safe approach for management of diabetes \[[@CR14], [@CR15]\]. However, so far no study has explored the impact of carbohydrate restricted diet intake on renal hypoxia, the major pathogenic event leading to end stage renal disease in type-1 diabetes. Furthermore the study also aims to gain insight into the possible influence of carbohydrate restricted diet intake on the functional and structural impairments associated with diabetic rats.

Methods {#Sec2}
=======

The experimental procedures on rats were approved by institutional animal ethics committee of Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala (Punjab), India. Male wistar rats 3 months old weighing 180-190 g were divided into five groups normal control (NC), diabetic control (DC), vehicle control (VC), CR control (Carbohydrate restricted only), CR + STZ (Carbohydrate restricted streptozotocin treated rats). Each rat from all groups was housed individually in cages. NC, DC, VC, groups were maintained on AIN-93 M carbohydrate during entire study period. The normal carbohydrate included: Cornstarch 465.6 g, casein 140 g, dextrinized cornstarch 155 g, sucrose 100 g, soyabean oil 40 ml, cellulose 50 g, l-cystine 1.8 g, choline bitartrate 2.5 g, tert-butylhydroquinone 0.008 g, AIN-93 M mineral mix 35 g, AIN-93 M vitamin mix 10 g, vitamin E 150 mg, vitamin k-0.75 mg for 1 kg carbohydrate (Table [1](#Tab1){ref-type="table"}) \[[@CR16]\]. Vitamin premix was stored in air tight zip lock plastic bag and kept at −20˙C until further use. Choline bitartrate was added separately to final carbohydrate due to its hygroscopic nature and vitamin E was used in carbohydrate preparation by mixing in soyabean oil. CR control, CR + STZ groups were exposed to carbohydrate restricted diet 2 weeks prior to start of the experiment and retained on this diet for the remaining period of 4 weeks after streptozotocin injection (45 mg/kg., *i.p*).Table 1Composition of the two different diets based on AIN-93-M for 1 kg diet \[[@CR10], [@CR16]\]S.NoIngredientsControl DietCarbohydrate Restricted Diet1.Cornstarch465.6 g408.4 g2.Dextrinized cornstarch155 g133 g3.Casein140 g200 g4.Sucrose100 g72.2 g5.Soyabean Oil40 g57.1 g6.Cellulose50 g58.6 g7.Mineral Mixture35 g50 g8.Vitamin Mixture10 g14.3 g9.L-Cystine1.8 g2.6 g10.Choline Bitartrate2.5 g3.6 g11.*Tert*-butylhydroquinone0.008 g0.005 g12.DL-α-Tocopherol150 mg220 mg13.Vitamin K10.75 mg1.07 mg

Carbohydrate energy restricted diet was composed of cornstarch 408.4 g, casein 200 g, dextrinized cornstarch 133 g, sucrose 72.2 g, soyabean oil 57.1 ml, cellulose 58.6 g, l-cystine 2.6 g, choline bitartrate 3.6 g, tert-butylhydroquinone 0.0055 g, AIN mineral mix 50 g, AIN-93 M vitamin mix 14.30 g, vitamin E 220 mg, vitamin K-1.07 mg for 1 kg carbohydrate (Table [1](#Tab1){ref-type="table"}). Carbohydrate restricted diet was formulated in such a manner when offering a 30% reduced quantity of diet consumed by NC and VC groups this diet offered equivalent quantity of all nutrients (proteins, fats, minerals, vitamins). Thus carbohydrate energy restricted group ingested 40% less carbohydrates compared to NC group \[[@CR10]\]. The feed consumed by NC, VC, DC group was monitored daily and average was calculated at 0, 2, 4 weeks of study protocol. Weight changes were recorded weekly from which final mean weights of all groups were obtained. Diabetes was induced by single dose of 45 mg/kg., *i.p* streptozotocin \[[@CR17]\] (Sigma Chemicals Co, St Louis, MO, USA). The status of diabetes in rats was confirmed by a tail-blood glucose level higher than 16.7 mmol/l 48 h after STZ injection \[[@CR18]\] and further blood glucose levels (tail vein, glucometer) were determined at 0, 2, 4 weeks in all study groups. Blood was collected from retro-orbital plexus of rats under light isoflurane anaesthesia and assessment of renal function was done after 4 weeks by biochemical estimations of blood urea nitrogen (BUN, GLDH-Urease method), serum creatinine (Jaffe's method), serum and urine albumin levels (BCG Dye method), proteinuria (24 h urine, Biuret method) was done using diagnostic kits from Tranasia Bio-medical Ltd. (Erba Mannheim) on chem-5 plus V2 semi autoanalyzer (Erba Mannheim). Rats were anesthetized by an intraperitoneal injection of sodium pentobarbital \[[@CR17]\], and both kidneys were isolated cleaned and weighed to calculate kidney/body weight ratio. Then rats were sacrificed by cervical dislocation and left kidney was taken for preparation of tissue homogenate (10% in cold phosphate buffer saline, pH 7.4). Further estimation of total protein content was done using bovine serum albumin as standard \[[@CR19]\]. A detailed schematic representation of the experimental design is depicted in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Experimental study design. Carbohydrate energy restriction was initiated 2 weeks prior to the start of study in carbohydrate restricted diet control group (CR control) and streptozotocin treated carbohydrate restricted rats (CR + STZ) group. Diabetes was induced at 0 week time in CR + STZ and DC group. Body weight was taken for each rat every 2 weeks period. After 4 weeks serum, renal tissue biochemical and histological examination was done in each group rats. NC (normal control), VC (Vehicle control), DC (Diabetic control)

Determination of antioxidant enzyme, lipid peroxidation and HIF-1α levels {#Sec3}
-------------------------------------------------------------------------

The level of lipid peroxidation in kidney homogenate was estimated by measuring the formation of thiobarbituric acid reactive substances (TBARS) \[[@CR20]\]. A standard plot was prepared using 1,1,3,3-tetramethoxypropane and values were expressed as nmol of malonaldehyde per milligram protein (nmol MDA/mg protein). Reduced glutathione levels were measured according to method of Boyne and Ellman \[[@CR21]\]. A standard curve was plotted using reduced glutathione and results were expressed as micromoles of reduced glutathione per milligram tissue protein (μmol/mg protein). Catalase enzyme activity was determined from analytical method as described by Gwinner et al. \[[@CR22]\]. Renal hypoxia was assessed by checking the levels of hypoxia inducible factor-1α in renal tissue by using rat HIF-1α ELISA kit (Code: ER0191, Wuhan Fine Biological Technology Co., Ltd. Wuhan, China) on i-Mark Microplate reader, BIO-RAD.

Histopathological examination {#Sec4}
-----------------------------

The right kidney was fixed in 10% formaldehyde solution. After fixation pieces of tissues were embedded into paraffin, cut into 5 μm slices and stained with hematoxylin and eosin stain to examine the extent of renal damage or protection and observed at 100X magnification (Leica DM 4000 microscope). Periodic acid Schiff staining was performed on 4 μm thick kidney sections to analyse the glomerular injury and observed at 400X magnification.

Statistical analyses {#Sec5}
--------------------

Statistical analyses were performed using Graph pad prism software-5 by applying one way ANOVA followed by bonferonni post hoc test for multiple comparison between groups. Data are shown as mean ± SD of *n* = 30, 6 per group. A *p*-value less than 0.05 (*P* \< 0.05) was considered as statistically significant.

Results {#Sec6}
=======

Effects of carbohydrate restriction on body weight changes in various study groups {#Sec7}
----------------------------------------------------------------------------------

Body weight was found to be significantly reduced at the beginning of zero week in carbohydrate restricted control and streptozotocin treated carbohydrate restricted groups in comparison to normal control, vehicle control and diabetic control groups (Fig. [2](#Fig2){ref-type="fig"}). During second week diabetic control group showed a significant decline of body weight 32.86% and 33.50% (*p* \< 0.001) compared with normal and vehicle control group also. The decline in body weight at second week among diabetic control, carbohydrate restricted control and carbohydrate restricted streptozotocin treated rat groups was found to be persistent towards fourth week of study also (Fig. [2](#Fig2){ref-type="fig"}). Importantly the body weight change in calorie restricted streptozotocin treated group was noticed to be significantly lower compared to carbohydrate restricted control group (*P* \< 0.001) at both second and fourth week of study period.Fig. 2Effects of carbohydrate restricted diet on body weight changes in streptozotocin induced diabetic rats at 0, 2, 4 weeks of treatment. NC: normal control, VC: vehicle control, DC: diabetic control with streptozotocin administration only, CR control: carbohydrate restricted diet treatment in normal rats, CR + STZ: carbohydrate restricted diet treatment in streptozotocin administered rats. Data are shown as mean ± SD. A *P*-value less than 0.05 (*P* \< 0.05) was considered statistically significant. \* Vs Normal control and vehicle control, ^@^ Vs Diabetic control, ^\#^ Vs CR control

Effects of carbohydrate restriction on kidney weight/body weight ratio in diabetic rats {#Sec8}
---------------------------------------------------------------------------------------

Streptozotocin treated diabetic control group showed a significant increase of kidney weight/body weight ratio compared to all other study groups. Both carbohydrate restriction control and carbohydrate restricted diabetic rat groups exhibited significantly higher kidney weight/body weight ratio (23%, *P* \< 0.01; 63%, *P* \< 0.001) as seen against normal control group ratio (Fig. [3](#Fig3){ref-type="fig"}). Carbohydrate restriction in streptozotocin treated group significantly lowered kidney weight/body weight ratio by 27% (*p* \< 0.001) compared to diabetic control group alone. Moreover a significant difference (*P* \< 0.001) of kidney/body weight ratio between carbohydrate restricted control and carbohydrate restricted streptozotocin treated groups was also observed in the present study (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Effects of carbohydrate restricted diet on kidney weight/body weight ratio\*1000 in streptozotocin induced diabetic rats after 4 weeks. NC: normal control, VC: vehicle control, DC: diabetic control with streptozotocin administration only, CR control: carbohydrate restricted diet treatment in normal rats, CR + STZ: carbohydrate restricted diet treatment in streptozotocin administered rats. Data are shown as mean ± SD. A P-value less than 0.05 (*P* \< 0.05) was considered statistically significant. \* Vs Normal control and vehicle control, ^@^ Vs Diabetic control, ^\#^ Vs CR control

Effects of carbohydrate restriction on blood glucose levels in diabetic rats {#Sec9}
----------------------------------------------------------------------------

At the baseline no significant changes were observed in blood glucose levels among various study groups. On second week**,** diabetic and carbohydrate restricted diabetic rat groups showed a markedly significant rise in blood glucose levels compared to normal control, vehicle control and carbohydrate restricted control groups (Fig. [4](#Fig4){ref-type="fig"}). Besides presence of high blood glucose levels in both diabetic control and carbohydrate restricted diabetic rat groups, the later showed a significantly lower blood glucose level by 7.39% (*P* \< 0.05) compared to diabetic control group at second week of study period (Fig. [4](#Fig4){ref-type="fig"}). This difference in hyperglycemia levels between carbohydrate restricted control and carbohydrate restricted diabetic rat groups was further noted to be significantly increased to 10.68% (*P* \< 0.001) at fourth week of study period.Fig. 4Effects of carbohydrate restricted diet on blood glucose levels in streptozotocin induced diabetic rats at 0, 2, 4 weeks of treatment. NC: normal control, VC: vehicle control, DC: diabetic control with streptozotocin administration only, CR control: carbohydrate restricted diet treatment in normal rats CR + STZ: carbohydrate restricted diet treatment in streptozotocin administered rats. Data are shown as mean ± SD. A *p*-value less than 0.05 (*P* \< 0.05) was considered statistically significant. \* Vs Normal control and vehicle control, ^@^ Vs Diabetic control, ^\#^ Vs CR control

Effects of carbohydrate restriction on renal function parameters in diabetic rats {#Sec10}
---------------------------------------------------------------------------------

In the present study**,** streptozotocin treated diabetic control group developed a high serum blood urea nitrogen levels compared with all other study groups. Carbohydrate restriction exposure in streptozotocin treated group significantly lowered BUN levels by 41% (*P* \< 0.001) from diabetic control group levels (Table [2](#Tab2){ref-type="table"}). Moreover diabetic control group also resulted in significant elevation of serum creatinine levels compared to all other study groups. Carbohydrate restriction intervention in diabetic group restored the serum creatinine levels to normalcy. The serum albumin levels was found to be reduced among diabetic control 44% (*P* \< 0.001), carbohydrate restriction control 35% (*P* \< 0.001) and carbohydrate restricted streptozotocin treated 57% (*P* \< 0.001) rat groups compared to normal control group (Table [2](#Tab2){ref-type="table"}). Streptozotocin administration in diabetic control group induced severe albuminuria and proteinuria compared to all other study groups. Carbohydrate restriction exposure in diabetic rat group reduced urinary albumin and protein excretion to normal range (Table [2](#Tab2){ref-type="table"}).Table 2Results are expressed as mean ± SD and analysed using one way ANOVA followed by bonferroni multiple comparison test for blood urea nitrogen, serum creatinine, serum albumin, albuminuria and proteinuria levelsNormal ControlVehicle ControlDiabetic ControlCR ControlCR + STZSerum Parameters BUN (mg/dl)21 ± 2.2417.6 ± 2.964.3 ± 8.4^a^34 ± 7.2^a,b^37.8 ± 6.6^a,b^ Creatinine (mg/dl)0.89 ± 0.1410.9750 ± 0.1191.73 ± 0.295^a^0.94 ± 0.064^b^1.17 ± 0.106^b^ Albumin (mg/dl)4.47 ± 0.4184.1 ± 0.2872.46 ± 0.691^a^2.9 ± 0.519^a^1.91 ± 0.218^a\#^Urine parameters Albumin (mg/24 h)77.00 ± 8.4071 ± 9.70551 ± 69^a^68 ± 11.10^b^78 ± 10^b^ Protein (mg/24 h)212 ± 60.10223 ± 49.901351 ± 138.10^a^116.0 ± 41.40^b^115.20 ± 38.70^b^Carbohydrate restriction control (CR control), carbohydrate restriction + streptozotocin treated (CR + STZ). ^a^Vs Normal and vehicle control, ^b^Vs Diabetic control, ^\#^ Vs CR control. *P*-value less than 0.05 (*P* \< 0.05) was considered statistically significant.

Effects of carbohydrate restriction on TBARS, antioxidant enzymes and HIF-1α levels in renal tissue of diabetic rats {#Sec11}
--------------------------------------------------------------------------------------------------------------------

Streptozotocin treatment resulted in a significant increase in renal tissue malonaldehyde levels in diabetic control group (56%, *P* \< 0.001) compared to normal control rat group levels (Fig. [5a](#Fig5){ref-type="fig"}). Carbohydrate restricted diet intake in diabetic rats significantly reduced renal tissue malonaldehyde levels equivalent to normal control group levels. Diabetic control group showed significantly lower 34% (*P* \< 0.01) renal tissue reduced glutathione levels compared to normal control group (Fig. [5b](#Fig5){ref-type="fig"}). Carbohydrate restriction control and carbohydrate restricted streptozotocin treated rat group exhibited significantly improved renal tissue reduced glutathione levels by 44.15% (*P* \< 0.05) and 68% (*P* \< 0.001) as seen against diabetic control group. Catalase enzyme activity was observed to be significantly lower in diabetic control group compared to all other study groups. Carbohydrate restriction control (CR control) and carbohydrate restricted diabetic rat groups showed catalase activity equivalent to normal control group (Fig. [5c](#Fig5){ref-type="fig"}). Moreover the diabetic kidneys displayed significantly lower hypoxia inducible factor-1 alpha (HIF-1alpha) levels in comparison to various other study groups (Fig. [5d](#Fig5){ref-type="fig"}). Conversely carbohydrate restriction exposure in diabetic rat group significantly elevated renal HIF-1α levels by 47.81% (*P* \< 0.001), 16.01% (*P* \< 0.01) as observed against diabetic control and normal control groups.Fig. 5Effects of carbohydrate restricted diet on MDA (malonaldehyde) levels (**a**), reduced glutathione levels (**b**), Catalase activity (**c**) and HIF-1α levels (**d**) in kidney homogenates of streptozotocin induced diabetic rats after 4 weeks. Results are expressed as mean ± SD and analysed using one way ANOVA followed by bonferroni multiple comparison test \* *P* \< 0.05 Vs Normal and vehicle control, ^@^ *P* \< 0.05 Vs diabetic control, ^\#^ *P* \< 0.05 Vs CR control

Effect of carbohydrate restriction on histological findings in diabetic rat kidney {#Sec12}
----------------------------------------------------------------------------------

In the present study diabetes induced renal morphological alterations were visualised **as** increased glomerular swelling, tubular dilation and tubular epithelial cell degeneration (Fig. [6](#Fig6){ref-type="fig"}, diabetic control group DC). Carbohydrate restriction exposure completely prevented these histological alterations induced by streptozotocin administration in rats (Fig. [6](#Fig6){ref-type="fig"}, CR + STZ group). Kidney sections of normal control, vehicle control, carbohydrate restriction control group (NC, VC, CR + STZ) showed normal glomeruli capsular space, no tubular vacoulations and degenerative changes. Periodic acid schiff staining revealed glomerular hypertrophy, proliferation of mesangial cells, and thickening of glomerular basement membrane in diabetic kidney sections (Fig. [7](#Fig7){ref-type="fig"}, Diabetic control DC). Carbohydrate restriction exposure completely prevented diabetes induced glomerular injury and structural changes (Fig. [7](#Fig7){ref-type="fig"}, CR + STZ group).Fig. 6Hematoxylin and eosin staining of kidney sections after 4 weeks of NC: normal control, VC: vehicle control, DC: diabetic control with streptozotocin administration only, CR control: carbohydrate restricted diet treatment in normal rats, CR + STZ: carbohydrate restricted diet treatment in streptozotocin administered rats. NC, VC representing normal glomerular architecture (![](40200_2017_331_Figa_HTML.gif){#d29e1158}) and tubular space (![](40200_2017_331_Figb_HTML.gif){#d29e1161}). The diabetic control (DC) kidney section showing glomerular swelling (![](40200_2017_331_Figc_HTML.gif){#d29e1164}) marked tubular vacoulation (![](40200_2017_331_Figd_HTML.gif){#d29e1167}) and degenerative changes. Carbohydrate restricted diet treatment in diabetic rat prevented glomerular enlargement and tubular dilation (CR + STZ), Magnification 100X Fig. 7Representive periodic acid schiff (PAS) staining in renal tissues of NC: normal control, VC: vehicle control, DC: diabetic control with streptozotocin administration only, CR control: carbohydrate restricted diet treatment in normal rats CR + STZ: carbohydrate restricted diet treatment in streptozotocin administered rats. The diabetic control rats developed more severe glomerular lesion such as glomerular hypertrophy, global mesangial expansion (![](40200_2017_331_Fige_HTML.gif){#d29e1180}) white arrow, basement membrane thickening. The absence of glomerular and mesangial alterations in carbohydrate restricted diet treated diabetic kidney section (![](40200_2017_331_Figf_HTML.gif){#d29e1183}) black arrow. Magnification: 400X

Discussion {#Sec13}
==========

Streptozotocin selectively damages insulin-producing pancreatic endocrine cells and can induce experimental hyperglycemia. Sustained hyperglycemia activates complex mechanisms that elevate oxidative stress resulting in renal complications including structural and functional changes \[[@CR17]\]. The renal hypoxia has been suggested as link between the oxidative stress and end stage renal disease. Diabetes induced oxidative stress can reduce renal oxygen tension (PO~2~) by impairing tubular electrolyte transport efficiency for Na^+^ reabsorption and mitochondrial uncoupling, these events further lead to the imbalance between metabolic demand and oxygen supply resulting in intrarenal tissue hypoxia \[[@CR17]\]. Normally kidneys respond to hypoxic state by up regulating the HIF regulated genes such as erythropoietin, vascular endothelial growth factor or hemeoxygenase-1 \[[@CR23]\]. However in diabetic kidneys **HIF** activation may be inadequate resulting in proteinuria, tubulointerstitial fibrosis and end stage renal diseases \[[@CR4], [@CR5]\]. Carbohydrate restriction has been documented to exert beneficial effects on various types of kidney disease, and also protect against cancer \[[@CR24], [@CR25]\]. In addition a study has reported that low carbohydrate ketogenic diet was able to protect against streptozotocin (STZ) induced pancreatic β cell damage in rats \[[@CR26]\]. Kume et al., 2010 \[[@CR12]\] showed that long term calorie restriction in mice abolished aging associated renal hypoxia by up regulation of Sirt1 (NAD-dependent histone deacetylase). However the information regarding the effect of carbohydrate restricted diet on type-1 diabetes mediated renal hypoxia which is a major pathogenic event initiating nephropathy but its possible outcomes on renal functional but histological alterations is not known.

Reduction in body weight occurs in type-1 diabetic rats due to excessive protein degradation and loss which was observed after 2 weeks of STZ administration in diabetic control group of present study. Carbohydrate restriction treatment in diabetic group resulted in a markedly significant weight loss despite the absence of proteinuria. Renal hypertrophy is major pathogenic hallmark of diabetic nephropathy and reductions in kidney weight is considered as an important feature of interventions that ameliorate diabetic nephropathy. In our findings kidney weight/body weight ratio was found to be higher in diabetic control rats. Intake of carbohydrate restricted diet in STZ treated rats caused marked reductions in kidney/body weight ratio indicating the beneficial effect of carbohydrate restriction on renal hypertrophy in diabetes. Moreover in the present study carbohydrate restricted diet treatment significantly lowered the elevated blood glucose levels in diabetic rats but these levels remained significantly higher as compared to normal control group. These observations suggest that carbohydrate restricted diet might exert beneficial effects on diabetic kidneys beyond anti-hyperglycaemic action also. Rise in BUN and serum creatinine level occurs in diabetes due to renal insufficiency originating from structural alterations occurring in glomerulus and tubules \[[@CR27], [@CR28]\]. Our findings are in line with these previous studies as we also observed similar pattern of elevated serum creatinine and BUN levels in diabetic rats. Carbohydrate diet restriction significantly attenuated the rise in serum creatinine and BUN levels in STZ treated rats. The results of present study also demonstrated low serum albumin levels in diabetic control group which may be a case due to renal insufficiency leading to loss of proteins \[[@CR29]\], and/or due to metabolic disturbance resulting in increased protein catabolism \[[@CR30]\] or insulin deficiency \[[@CR31]\]. Surprisingly**,** low serum albumin levels were also observed in CR control and CR + STZ rat groups without any significant proteinuria. These effects could be explained partially by the shift of metabolic demand for energy towards non carbohydrate substrate for energy like proteins, which in this case may be less available for synthesis of albumin or low insulin levels. Proteinuria develops in diabetic kidney diseases predominantly due to disturbances in the glomerular filtration barrier (podocyte injury) resulting in leakage of proteins in urine \[[@CR32]\]. Similarly in the present study diabetic rats displayed massive 24 h proteinuria from second week progressing to fourth week period. Carbohydrate diet restriction treatment completely abolished the raised proteinuria levels in diabetic rats. These effects may be likely due to the reduced damage of the glomerular filtration barrier in type-1 diabetic rats subjected to the carbohydrate restricted diet.

Hyperglycemia induced oxidative stress in diabetes can lead to depletion of tissue antioxidant levels \[[@CR33]\] which can result in mitochondrial damage, peroxidation of cell membrane lipids, apoptosis \[[@CR34]\]. The vulnerability of renal tissue to glucotoxicity can be prominently mediated by excessive generation of superoxide radicals (O~2~ ^−^). The enzyme superoxide dismutase (SOD) rapidly catalyses the conversion of O~2~ ^−^ to hydrogen peroxide (H~2~O~2~) which is further inactivated by catalase \[[@CR35]\]. Importantly the catalase deficiency was demonstrated to exacerbate renal injury in diabetic mice \[[@CR36]\]. Several studies have shown that calorie restriction can reduce aging associated increase in mitochondrial ROS production and oxidative stress derived damage to proteins and lipids \[[@CR37]--[@CR39]\]. Another study, has demonstrated that carbohydrate restricted diet can increase stress resistance in rats exposed to exhaustive exercise and prevent oxidative damage in brain \[[@CR10]\].

In the present study diabetic kidneys displayed lower reduced glutathione (GSH) content, catalase activity and high MDA levels which are indicative of increased oxidative stress. Carbohydrate restricted diet intervention in diabetic rats reduced oxidative stress by elevating the renal tissue GSH levels, catalase activity and thus prevented the formation of tissue lipid peroxides. Moreover diabetic rats exhibited low levels of hypoxia inducible factor (HIF) in renal tissue which might have resulted in renal hypoxia, the final common pathogenic event ensuing the nephropathy. The results from present study demonstrated that carbohydrate restriction by up regulating the renal tissue HIF-1 alpha levels opposed the development of renal hypoxia in diabetic rats. Interestingly, a study has shown that administration of superoxide radical scavenger tempol for 2--14 days enhanced the HIF-1α levels in diabetic kidneys \[[@CR40]\]. In addition the acute treatment with tempol was reported to improve the intrarenal tissue hypoxia by countering the diabetes induced superoxide O~2~ˉ generation \[[@CR9]\]. Thus it might be possible that in the present study the carbohydrate restricted diet prevented the renal hypoxia by augmenting the antioxidant defense and thereby leading to the HIF-1α activation.

Histological findings from hematoxylin and eosin (H & E) staining revealed marked structural alterations as visualised by glomerular swelling, tubular vacuolation and degenerative changes in diabetic kidney sections. Whereas**,** mesangial expansion and glomerular hypertrophic changes in kidney sections from streptozotocin induced diabetic group were confirmed by periodic acid Schiff (PAS) staining. The results of the present study showed that the intake of carbohydrate energy restricted diet attenuated any glomerular and tubular changes in kidneys of diabetic rats.

Thus carbohydrate restricted diet intake resulted in a marked decline of body weight at fourth week period but improved the kidney/body weight ratio in diabetic rats. Moreover the dietary intervention treatment reduced the levels of oxidative stress indicator TBARS by enhancing the reduced glutathione levels and catalase activity in diabetic kidneys. Diabetes induction resulted in renal hypoxia as observed by the lower levels of HIF-1α found in kidneys of streptozotocin treated rats. Carbohydrate restricted diet treatment upregulated the levels of renal HIF-1α in diabetic rats and prevented the occurrence of hypoxic stress. Further this antioxidant defense activation and HIF-1α upregulation abolished the renal functional and structural alterations in diabetic rat kidneys.

Conclusion {#Sec14}
==========

Our results demonstrated that type-1 diabetic rats fed 30% reduced amount of carbohydrate-energy-restricted (CR) diet exhibited renoprotective effects compared to diabetic rats fed *ad libitium* normal control diet. The restricted diet treatment reduced oxidative stress and prevented occurrence of hypoxia in diabetic kidneys by enhancing tissue antioxidant enzyme and HIF-1 α levels. Furthermore histological findings from kidney sections from CR treated diabetic rats showed absence of glomerular hypertrophy, mesangial proliferation and tubular changes. Thus we conclude that carbohydrate-energy-restricted diet might be a useful therapeutic approach for prevention of nephropathy in type-1 diabetes. Further studies are required to explore the impact of carbohydrate diet restriction on various other molecular signals regulating the HIF-1α levels in diabetic rat kidneys.
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